• Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Search
FDAReview.org
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate

Monthly Archives: April 2020

Private Enterprise Continues to Flatten the Curve

Raymond March - April 28, 2020
0

Governments Can’t Plan Economy’s Reopening

Benjamin Powell - April 18, 2020
0

Economy Prosperity or Pandemic Protection: Why Not Both?

Raymond March - April 15, 2020
0

Cut Regulations and Get COVID-19 Drugs to Patients

Raymond March - April 8, 2020
0

Drug Is Safe and Sometimes Works, Let All COVID-19 Patients Take...

Ronald L. Trowbridge - April 2, 2020
0

Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus

Raymond March - April 1, 2020
0
© 2020 Independent Institute, 100 Swan Way, Oakland CA 94621-1428 | (510) 632‑1366.
Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.